HomeAI · summaries
Storia in 3 fonti
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
Alembic Pharmaceuticals’ cumulative tally of USFDA ANDA approvals has risen to 244, comprising 224 final approvals and 20 tentative approvals
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
economictimes.indiatimes.com
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at USD 1.4 bn
Alembic Pharmaceuticals and NATCO Pharma received tentative USFDA approval for generic Olaparib tablets. This approval is for a cancer drug, which is a generic equivalent of…
- ·
thehindubusinessline.com
Alembic Pharma partner NATCO gets USFDA tentative nod for generic Olaparib tablets; US market size at $1.4 bn
Alembic Pharmaceuticals’ cumulative tally of USFDA ANDA approvals has risen to 244, comprising 224 final approvals and 20 tentative approvals
